Amgen

NEULASTA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / NEULASTA – J2506

Manufacturer:

Amgen

Name:

NEULASTA

HCPCS Code Descriptor:

Injection, pegfilgrastim, excludes biosimilar, 0.5 mg

Category:

J Code

HCPCS:

J2506

NDC(s):

55513-0190-01, 55513-0192-01

Primary Type:

Oncology Colony Stimulating Factor

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

NEULASTA is an Oncology Colony Stimulating Factor drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2506 is aligned to the drug NEULASTA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/22

HCPCS Effective Date:

4/1/23

HCPCS Short Description:

Inj pegfilgrast ex bio 0.5mg

Billing and Coding Guide:

https://www.amgensupportplus.com/-/media/Themes/Amgen/amgensupportplus-com/Amgensupportplus-com/documents/amgensupportplus/Neulasta-Neupogen-Physician-Billing-and-Coding-Guide.pdf

Patient Assistance:

https://www.amgenassist.com/copay

https://www.amgenassist.com/copay